Dailly, E.

Professor - Hospital Practitioner

Publications

P277

Gut Microbes 2024, 16, 2347021.

Efficacy of an inulin-based treatment on intestinal colonization by multidrug-resistant E. coli: insight into the mechanism of action.

Ishnaiwer, M. Le Bastard, Q. Naour, M. Zeman, M. Dailly, E. Montassier, E. Batard, E. Dion, M.

https://doi.org/10.1080/19490976.2024.2347021

P274

J. Appl. Microbiol. 2023, lxad223. 

Pantoprazole promotes sustained intestinal carriage of multi-drug resistant Escherichia coli in amoxicillin-treated mice.

Moaligou, C. Dion, M. Ishnaiwer, M. Dailly, E. Batard, E. Javaudin, F.

https://doi.org/10.1093/jambio/lxad223

P263

J. Antimicrob. Chemother. 2023, 78, 1378-1385.

A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections-a monocentre quality improvement project. 

Lagarde, C. Bouras, M. Le Floch, R. Hourmant, Y. Grillot, N. Bourdiol, A. Mahe, P.-J. Demeure Dit Latte, D. Gregoire, M. Dailly, E. Bellouard, R. Asehnoune, K. Cinotti, R. Roquilly A.

https://doi.org/10.1093/jac/dkad094

P262

J. Antimicrob. Chemother. 2023, 78, 965-974.

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis. 

Bellouard, R. Rambaud, A. Delaunay, C. Dailly, E. Lecomte, R. Deschanvres, C. Leroy, A.-G. Boutoille, D. Le Turnier, P. Gregoire, M.

https://doi.org/10.1093/jac/dkad030

P261

Antibiotics 2023, 12,123.

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach. 

Coste, A. Bellouard, R. Deslandes, G. Jalin, L. Roger, C. Ansart, S. Dailly, E. Bretonnière, C. Gregoire, M.

https://doi.org/10.3390/antibiotics12010123

Autres publications scientifiques

PS28

J Antimicrob Chemother 2023, 78(12):2919-2925.

Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.

Hervochon, C. Hennart, B. Leroy, A.-G. Corvec, S. Boutoille, D. Senneville, E. Sotto, A. Illes, G. Chavanet, P. Dubée, V. Bleibtreu, A. De Carné, M.-C. Talarmin, J.-P. Revest, M. Castan, B. Bellouard, R. Dailly, E. Allorge, D. Dinh, A. Le Turnier, P. Grégoire, M.

https://doi.org/10.1093/jac/dkad331

PS25

J Antimicrob Chemother 2023, dkad094.

A multifaceted strategy to optimize pharmacokinetics of antimicrobial therapy in patients with hospital-acquired infections—a monocentre quality improvement project.

Lagarde, C. Bouras, M. Le Floch, R. Hourmant, Y. Grillot, N. Bourdiol, A. Mahé, P.-J. Deumeure Dit Latte, D. Grégoire, M. Dailly, E. Bellouard, R. Asehnoune, K. Cinotti, R. Roquilly, A.

https://doi.org/10.1093/jac/dkad094

PS24

J Antimicrob Chemother 2023, 8, 965-974.

Development and validation of a dosing nomogram for continuous infusion cloxacillin in infective endocarditis.

Bellouard, R. Rambaud, A. Delaunay, C. Dailly, E. Lecomte, R. Deschanvres, C. Leroy, A.-G. Boutoille, D. Le Turnier, P. Grégoire, M.

https://doi.org/10.1093/jac/dkad030

PS23

Antibiotics 2023, 12, 123.

Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach.

Coste, A. Bellouard, R. Deslandes, G. Jalin, L. Roger, C. Ansart, S. Dailly, E. Bretonnière, C. Grégoire, M.

https://doi.org/10.3390/antibiotics12010123